crown

Subscribe Now

FOLLOW US

Sign in

covishield

PAGE 2

Amid Covid surge, Tricity short of vaccine doses

chandigarh news

Updated on Apr 8, 2023 20:35 IST

Over the past week, numerous individuals have been turned away empty-handed from dispensaries and hospitals as a shortage of vaccines has left them unable to receive their much-needed jabs. (AFP)

Serum Institute of India offers 20 mn free Covishield doses to govt

A healthcare worker administers a booster dose of Covid vaccine to a woman during a special drive in Srinagar. (PTI)

Updated on Dec 29, 2022 20:49 IST

Serum Institute, Bill Gates get Bombay high court notice over ‘vaccine death’

Serum Institute of India, the world’s largest vaccine maker, manufactured Covishield as a vaccine for the coronavirus disease.

Published on Sep 3, 2022 02:02 IST

SII has stockpile of 200 mn doses; India better prepared to fight Covid: CEO

Serum Institute of India CEO Adar Poonawalla speaks at the 'AIMA Leadership Conclave' in New Delhi on Tuesday,

Updated on Apr 12, 2022 18:12 IST

Covishield, Covaxin costs cut to ₹225 per dose for private hospitals

A senior citizen gets inoculated with a booster dose of Covid vaccine, in Noida. (Sunil Ghosh/HT photo)

Updated on Apr 9, 2022 21:25 IST

Day before 'precautionary' doses for all, Covishield, Covaxin prices slashed

Covishield (left) and Covaxin (right) prices slashed at <span class='webrupee'>₹</span>225 per dose at private hospitals

Updated on Apr 9, 2022 10:45 IST

Covishield booster shots to be priced at ₹600 plus taxes: Adar Poonawalla

Covishield has been manufactured by Pune-based Serum Institute of India, which is the world's largest vaccine maker.

Updated on Apr 8, 2022 13:24 IST

Covishield dosage gap to stay at 12-16 weeks: Govt

A health worker administers a dose of Covid-19 vaccine to a student in Surat. (PTI)

Updated on Mar 29, 2022 24:47 IST

Expert body suggests reducing gap between Covishield doses

In the early phase of Covid-19 inoculation, the gap was 4-6 weeks, which was later increased to 6-8 weeks, and then to 12-16 weeks. (PTI)

Updated on Mar 21, 2022 24:32 IST

Second Covishield dose can be given between 8-16 weeks: NTAGI

NTAGI provides guidance and advice to the Union Health Ministry on immunisation services for the effective control of vaccine-preventable diseases in the country.

Published on Mar 20, 2022 10:59 IST

Covishield, Covaxin get conditional market nod

Gurugram: A health worker administers a dose of Covid-19 vaccine to a beneficiary, at a vaccination centre in Gurugram, Thursday, January 27, 2022. (PTI Photo)(PTI01_27_2022_000068A) (PTI)

Published on Jan 27, 2022 18:31 IST

Covaxin, Covishield to be available in hospitals, clinics; apex body gives nod

Covaxin, Covishield to be available in regular market, apex body gives nod

Updated on Jan 27, 2022 09:50 IST

Evening brief from HT: Akhilesh dismisses opinion polls on TV as ‘opium polls’

Samajwadi Party national president Akhilesh Yadav

Published on Jan 26, 2022 11:39 IST

Covaxin, Covishield to get cheaper after nod, jabs to be priced at ₹275

According to current rates, each dose of the Bharat Biotech-produced Covaxin is priced at <span class='webrupee'>₹</span>1,200, while Serum Institute’s Covishield costs <span class='webrupee'>₹</span>780 in private facilities. (Representational image)

Published on Jan 26, 2022 11:27 IST

Panel pitches full market nod for Covaxin, Covishield

A healthworker administers a dose of Covid-19 vaccine to a beneficiary at a vaccination centre, in Gurugram. (PTI photo)

Updated on Jan 20, 2022 24:38 IST

SEC recommends Covaxin, Covishield for full market authorisation: Report

A doctor being inoculated with a booster dose of Covid-19 vaccine, at Ganga Ram Hospital, in New Delhi. (Amal KS/HT Photo)

Updated on Jan 19, 2022 17:14 IST

Govt seeks more data for full market clearance to Covishield, Covaxin

Patna: A health worker administers a COVID-19 vaccine dose to a teenanger, at SKM Hall in Patna, Friday, Jan. 14, 2022. (PTI Photo)(PTI01_14_2022_000164A) (PTI)

Updated on Jan 14, 2022 20:10 IST

Same vaccine to be administered as ‘precaution’ 3rd dose: Centre

A Covaxin vial is seen during a vaccination drive against the Covid-19 coronavirus during a vaccination drive for youths in the 15-18 age group, at a school in Kolkata on January 4, 2022. (Photo by DIBYANGSHU SARKAR / AFP)

Published on Jan 5, 2022 11:07 IST

Centre rejects reports of expired vaccines being administered as ‘misleading’

Bharat Biotech's Covaxin vaccine is the only vaccine with emergency use listing for the 15-18 age group in India.

Published on Jan 3, 2022 11:15 IST

Give full authorisation to Covishield: Serum Institute of India

Ranchi, Dec 28 (ANI): A beneficiary receives a dose of the COVID-19 vaccine during a door-to-door vaccination programme, at Deoghar, in Ranchi on Tuesday. (ANI Photo) (Somnath Sen)

Updated on Dec 31, 2021 17:37 IST

Serum Institute of India applies for full approval of Covishield Covid vaccine

Serum Institute, which is also the world's biggest vaccine maker, was granted approval for emergency use of Covishield in India at the beginning of the year.

Published on Dec 31, 2021 08:18 IST

Omicron: Will India allow booster dose? Here's what central expert panel said

More than 60 countries across the world have already authorised booster doses of the Covid-19 vaccine, said the central government in a written reply to Parliament this week.

Published on Dec 11, 2021 02:23 IST

Expert panel to meet over booster shot today

Serum Institute of India sought approval for Covishield as a booster dose from India’s drugs regulator citing adequate stock of the vaccine in the country and a demand for a booster shot due to the emergence of new coronavirus variants. (Representative use)

Published on Dec 9, 2021 18:16 IST

News updates from HT: TMC MPs to meet Shah today to seek govt's stance on AFSPA

People participate in a demonstration in Nagaland’s Mon district on Sunday night following the killings of civilians. (PTI)

Updated on Dec 8, 2021 07:14 IST

Covishield production to be halved; Adar Poonawalla says he's in dilemma

Serum has already written to the government seeking clarification on whether it would need booster doses.

Published on Dec 8, 2021 05:48 IST

Serum Institute seeks DCGI nod for Covishield booster shot amid Omicron scare

Prakash Kumar Singh, director of government and regulatory affairs at Pune-based SII, mentioned in his letter to DCGI that the UK’s Medicines and Healthcare products regulatory agency has already approved the booster doses of AstraZeneca ChAdOx1 nCoV-19 vaccine.

Published on Dec 1, 2021 17:45 IST

Serum Institute of India resumes exports of Covishield vaccine to COVAX facility

SII said its supply of doses through COVAX was expected to increase substantially into the first quarter of 2022.

Published on Nov 26, 2021 12:54 IST

Delay in SII’s first shipment to Nepal under Covax

Serum Institute may ship 20-30 million doses of Covishield by the end of the year, the company has said in the past. (AFP)

Updated on Nov 23, 2021 21:17 IST

Serum Institute to resume supply of Covishield to COVAX: Reports

Adar Poonawalla, chief executive officer of Serum Institute of India. (File photo)

Published on Nov 23, 2021 05:57 IST

New Zealand adds Covaxin, Covishield to list of recognised Covid-19 vaccines

Covishield (left) and Covaxin

Published on Nov 17, 2021 11:28 IST

1
2

Home / India News / Covishield

© 2026 HindustanTimes